Author Question: A patient will begin taking the protease inhibitor combination Kaletra (lopinavir/ritonavir). What ... (Read 110 times)

daltonest1984 · **on:** Jul 23, 2018

A patient will begin taking the protease inhibitor combination Kaletra (lopinavir/ritonavir). What information will the nurse include when teaching the patient about dietary changes?

a. Consume a low-cholesterol diet.
b. Consume more acidic foods.
c. Take the pill on an empty stomach.
d. Take the pill with fatty foods.

Question 2

The nurse is caring for a patient who is HIV-positive and has been receiving antiretroviral therapy for several months. The nurse experiences a needlestick injury resulting in exposure to the patient's blood.

The nurse asks the Occupational Health nurse if treatment is necessary. How will the Occupational Health nurse respond?
a. No treatment is necessary since the patient is receiving antiretroviral therapy.
b. We will treat you if the patient's VL is > 20 copies/mL.
c. You will require 4 weeks of antiretroviral therapy.
d. You will undergo HIV testing and will be treated if you are positive.

kingdude89 · **Reply #1 on:** Jul 23, 2018

Answer to Question 1

ANS: A
Protease inhibitors generally cause elevations of cholesterol and triglycerides, so patients should be counseled to consume a low-fat diet.

Answer to Question 2

ANS: C
Persons exposed to the blood of HIV-infected patients should receive 4 weeks of antiretroviral therapy.